Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

COLL - Collegium Pharmaceutical, Inc.... | Finranks

Home

/

COLL

C

Collegium Pharmaceutical, Inc. (COLL)

NMS – Real Time Price. Currency in USD

25.98

0.00 (0.00%)

Market open: Aug 12, 2026, 3:06 PM EDT

26.38

+0.40 (1.56%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

781M

631M

567M

464M

Cost of goods sold

-317M

-254M

-241M

-252M

Gross Profit

463M

377M

326M

212M

Operating expenses (excl. COGS)

-276M

-186M

-151M

-142M

Operating Income

187M

191M

175M

69M

Non-operating income, total

-94M

-93M

-100M

-98M

Pretax income

93M

99M

76M

-29M

Equity in earnings

0

0

0

0

Taxes

-30M

-29M

-28M

4M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

63M

69M

48M

-25M

Discontinued operations

0

0

0

0

Net income

63M

69M

48M

-25M

Dilution adjustment

6M

6M

6M

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

1.69B+1.3%

1.66B+45.5%

1.14B-2.6%

1.17B

Total current assets

691M

482M

538M

420M

Total non-current assets

995M

1.18B

606M

754M

Total liabilities

1.38B-3.5%

1.43B+51.4%

948M-3.2%

979M

Total current liabilities

440M

510M

458M

434M

Total non-current liabilities

944M

925M

490M

546M

Total equity

302M

229M

195M

195M

Total liabilities & shareholders' equities

1.69B

1.66B

1.14B

1.17B

Total debt

936M-4.4%

980M+45.3%

674M-4.9%

709M

Name

2025

2024

2023

2022

Cash from operating activities

329M

205M

275M

124M

Cash from investing activities

-64M

-288M

-71M

-574M

Cash from financing activities

-110M

-61M

-140M

437M

Free cash flow

328M+61.1%

203M-25.9%

274M+123.7%

123M